[On a new possibility in the management of exudative radiodermatitis].
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000532:radiotherapy; D002280:Basal Cell Carcinoma / Q000532:radiotherapy; D004431:Ear, External; D005122:Exudates and Transudates; D005542:Forearm; D006801:Humans; D008297:Male; D009506:Nevus / Q000532:radiotherapy; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D011230:Precancerous Conditions; D011855:Radiodermatitis / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000532:radiotherapy
D000893:Anti-Inflammatory Agents; D010113:Oxyphenbutazone
Uber eine neue Behandlungsmöglichkeit der exsudativen Strahlenreaktion der Haut.